ISDA: 3F7G

Deposition Date 2008-11-09

Release Date 2009-03-17

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3F7G

Keywords:

APOPTOSIS

Title:

Structure of the BIR domain from ML-IAP bound to a peptidomimetic

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.20

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 32

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Baculoviral IAP repeat-containing protein 7
Gene (Uniprot):BIRC7
Chain IDs:A, B, C, D, E
Chain Length:140
Number of Molecules:5
Biological Source:Homo sapiens

UniProt ID:Q96CA5 Pfam ID:PF00653

Ligand Molecules

389

P33

Primary Citation

Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold

Cohen, F, Alicke, B, Elliott, L.O, Flygare, J.A, Goncharov, T, Keteltas, S.F, Franklin, M.C, Frankovitz, S, Stephan, J.P, Tsui, V, Vucic, D, Wong, H, Fairbrother, W.J, Zobel, K, Wang, L, Varfolomeev, E, Franklin, M.C, Elliott, L.O, Wallweber, H.J, Okawa, D.C, Flygare, J.A, Vucic, D, Fairbrother, W.J, Deshayes, K, Vucic, D, Franklin, M.C, Wallweber, H.J, Das, K, Eckelman, B.P, Shin, H, Elliott, L.O, Deshayes, K, Salvesen, G.S, Fairbrother, W.J, Franklin, M.C, Kadkhodayan, S, Ackerly, H, Alexandru, D, Distefano, M.D, Elliott, L.O, Flygare, J.A, Vucic, D, Deshayes, K, Fairbrother, W.J.Show

J.Med.Chem. 52 1723 1730 (2009)

PMID: 19228017 DOI: 10.1021/jm801450c

Abstact

A series of IAP antagonists based on an azabicyclooctane scaffold was designed and synthesized. The most potent of these compounds, 14b, binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domain of c-IAP1 with K(i) values of 140, 38, and 33 nM, respectively. These compounds promote degradation of c-IAP1, activate caspases, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells. Finally, compound 14b inhibits tumor growth when dosed orally in a breast cancer xenograft model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures